Table 2 Demographics for each data split
African Descent | Caucasian | Hispanic | Other | Asian | Null Race | Male | Female | Age (18–25.999) | Age (26–40.999) | Age (41–64.999) | Age (65 + ) | Remission | Total n** | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Train* | 575 (7.82%) | 5584 (75.97%) | 142 (1.93%) | 136 (1.85%) | 692 (9.41%) | 221 (3%) | 2672 (36.35%) | 4678 (63.64%) | 799 (10.87%) | 2391 (32.53%) | 3543 (48.2%) | 617 (8.39%) | 3,173 (43.17%) | 7,350 (81.28%) |
Test* | 57 (6.5%) | 677 (77.37%) | 22 (2.52%) | 13 (1.48%) | 77 (8.8%) | 29 (3.3%) | 323 (36.91%) | 552 (63.1%) | 97 (11.09%) | 263 (30.1%) | 445 (50.86%) | 70 (8%) | 380 (43.43%) | 875 (9.67% |
Validation* | 64 (7.83%) | 633 (77.47%) | 21 (2.57%) | 16 (1.96%) | 60 (7.34%) | 23 (2.82%) | 300 (36.72%) | 517 (63.28%) | 78 (9.55%) | 249 (30.48%) | 419 (51.29%) | 71 (8.69%) | 349 (42.71%) | 817 (9.03%) |
Total** | 696 (7.7%) | 6,894 (76.24%) | 185 (2.05% | 165 (1.82%) | 829 (9.17) | 273 (3.02%) | 3,295 (36.44%) | 5,747 (63.56%) | 974 (10.77%) | 2,903 (32.11%) | 4,407 (48.74% | 758 (8.38%) | 3,902 (43.15%) | 9,042 (100%) |
